RAD51 and neoplasm: Quantitative PCR analysis confirmed that CCC‐002 markedly downregulated the mRNA expression of RAD51 in KP‐4 cells (Figure 4F), while KR12 treatment did not downregulate the RAD51 expression in cultured PDAC cells and KP‐4 tumor tissues (Figure S5).